Telemedicine is a growing resources for Houstonians, but here's what you need to know about tapping into digital health care. Ian Hooton/Getty Images

When health issues crop up, people often have to decide where best to seek medical attention, with urgent care and the emergency room being potential destinations. But for more and more Houston residents, their smartphone is now the preferred way to see and talk to a doctor.

Telemedicine visits, also known as virtual care, typically last less than 20 minutes, often cost less than $50 and enable people to connect 24/7 with a health care provider via a smartphone, tablet or personal computer to help diagnose and treat certain medical conditions. While nearly 40 percent of Americans said they are interested in using telemedicine in the future to access care a separate J.D. Power survey found nationwide telehealth adoption is currently as low as 10 percent.

Closing this gap by expanding the use of virtual care may prove beneficial, as this technology can provide consumers improved convenience and lower costs. In fact, 68 percent of patients rated their telemedicine visit a "nine" or "10" on a 10-point satisfaction scale; 74 percent had their care concern resolved during the first visit; and net savings per virtual visit exceeded $120.

To help people take advantage of this emerging technology, here are four tips to consider:

Identify Available Resources
Among people who had not used telemedicine, the J.D. Power survey found that 37 percent said they did not know if they had access to this technology. To find telemedicine resources that may be available to you, check with your hospital or care provider group, health insurance plan or employer. In fact, nearly nine out of 10 employers are offering telemedicine to their employees, while 76 percent of U.S. hospitals already connect patients and care providers using video or other technology. For Medicare beneficiaries, some Medicare Advantage plans are offering coverage for telemedicine and resources to access virtual care, in some cases at no out-of-pocket cost.

For Houston residents, most people enrolled in UnitedHealthcare employer-sponsored plans have coverage for virtual physician visits, giving plan participants secure, online access to a physician via mobile phone, tablet or computer 24 hours a day. Several Houston-area hospitals and provider groups have also introduced virtual care resources, and changes in state regulations in 2017 helped spur additional national telemedicine companies to start serving the market.

Understand Appropriate Uses
While telemedicine may have the potential to help treat other health issues, the technology is most widely used to address minor and nonemergency medical conditions, including allergies, flu, pinkeye, and rashes. Telemedicine is also emerging as a helpful resource for behavioral health services, making it more convenient for people to access this type of care. If needed, doctors can prescribe medications and send prescriptions to local pharmacies for pickup. While people who experience a significant or serious medical issue should go to the emergency room (ER), it is important to recognize that about 25 percent of ER visits typically involve conditions that could appropriately be addressed with a virtual visit.

Keep Your Primary Care Physician
Telemedicine may be ideal for treating minor and nonemergency medical issues, but it is important for people to maintain a relationship with a primary care physician for wellness checkups, diagnostics, management of long-term conditions and some urgent and non-urgent treatments. As telemedicine programs evolve, people may have the option to use virtual visits to access primary care and maintain an on-going relationship with their preferred doctor.

Other Connected Devices
Consumers can consider other connected devices to help access care and potentially improve their health, ranging from smartwatches and activity trackers to continuous blood glucose monitors and connected asthma inhalers. These connected devices – and others like them – may provide important real-time information and offer people actionable feedback about their behavior patterns, while helping make it possible for care providers to counsel patients to more effectively follow recommended treatments.

Making telemedicine more widely available – and used – may be especially important for people with chronic conditions and the 20 percent of the U.S. population that lives in rural areas where access to health care, particularly specialty care, is often lacking. By considering these tips, people may make the most of telemedicine resources as part of their journey toward managing their health.

------

Dave Milich is the CEO of UnitedHealthcare of Texas.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”